Xconomy Forum: What’s Hot in Boston Biotech

This event is sold out, but we invite you to sign up for the event waitlist here.

It’s no secret that biotech is feeling it once again. Stocks are way up, and startups are seizing the opportunity to sail through a wide-open IPO window. That bull market isn’t just generating big returns for investors, it’s helping fuel the next round of innovation. Ambitious startups are sprouting up, sparked by science that is turning heads. New, nontraditional sources of cash are turning their attention to life sciences, creating unlikely options for fledgling biotechs that simply weren’t imagined a short time ago. But which ideas are generating the most buzz? What’s it going to take for the grandiose visions to become reality? And what does it all mean for drug discovery and health? Join Xconomy as we bring together some of the Boston biotech scene’s top innovators, venture capitalists, and executives, who are at the forefront of some of the biggest new ideas in life sciences.

Confirmed Speakers

  • Michael Bonney
    • CEO, Cubist Pharmaceuticals
  • Douglas Williams
    • EVP, Research and Development, Biogen Idec
  • John Maraganore
    • CEO, Alnylam Pharmaceuticals
  • Rob Armstrong
    • former VP, Global External Research and Development, Eli Lilly
  • David Berry
    • CEO, Seres Health; Partner, Flagship Ventures
  • Kevin Bitterman
    • Interim CEO, Editas Medicine; Partner, Polaris Partners
  • Katrine Bosley
    • Entrepreneur-in-residence, The Broad Institute
  • Richard Brudnick
    • VP, Business Development, Biogen Idec
  • Jason Rhodes
    • President and CFO, Epizyme
  • Nancy Simonian
    • CEO, Syros Pharmaceuticals
  • Roger Stein
    • Chief Analytics Officer, State Street Global Exchange
  • Robert Urban
    • Head, J&J Innovation Center, Boston
  • Feng Zhang
    • Professor of Biomedical Engineering, MIT

Follow us on Twitter:




Registration: 12:30 – 1:30 pm

Program: 1:30 – 5:30 pm

Networking Reception: 5:30 – 6:30 pm

Full agenda here

Biogen Idec
Cubist Pharmaceuticals   Health Advances ICON   Mintz Levin Rasky Baerlein